Mark
Sapp
Senior Director, Global Digital Health Products
|
The Janssen Pharmaceutical Companies of Johnson & Johnson
Mark leads the Janssen Digital Health and Digital Innovation teams within Johnson & Johnson Technology. He and his teams are responsible for identifying, creating and deploying innovative technology for patient use throughout the world. This technology is used to develop and gather new types of data from our patients that help drive insights into disease. Mark has been leading this function within Janssen for the past 7 years. Prior to joining Janssen, Mark has held leadership positions in a number of large, multinational companies in the healthcare and life sciences technology markets, and has also been a founding member of several successful start-up companies. His expertise includes software and technology development, and product and portfolio management. Mark enjoys working directly with solution stakeholders to create things that make healthcare – and peoples’ lives - better.
